Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1656

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1656
---
 beginning December 31, 2025. For accounting and
disclosure purposes, no fair value has been ascribed to these stock option awards as of December 31, 2024 as the grant date (as defined
in ASC 718) had not been established.

Restricted Stock Units

Compensation cost for service-based RSUs is based
on the grant date fair value of the award, which is the closing market price of the Company’s common stock on the grant date multiplied
by the number of shares awarded.

The following table summarizes the Company’s
RSU activity for the year ended December 31, 2024:

     Number
                                            of
                                            Units  
     Weighted
                                            Average 
                                            Grant Date Fair 
                                            Value 
  
    Unvested balance, December 31, 2023 
          -
                                               
    $- 
  
    Granted 
     -  
     - 
  
    Vested 
     -  
     - 
  
    Forfeited 
     -  
     - 
  
    Unvested balance, December 31, 2024 
     -  
    $- 

The following table summarizes the Company’s
RSU activity for the year ended December 31, 2023:

    Number of
    Units  
    Weighted
    Average
    Grant 
    Date Fair
    Value 
  
    Unvested balance, December 31, 2022 
     -  
    $     - 
  
    Granted 
     4,270  
     52.20 
  
    Vested 
     (4,270) 
     52.20 
  
    Forfeited 
     -  
     - 
  
    Unvested balance, December 31, 2023 
     -  
    $- 

The Company recognized $0 of compensation expense
related to vested RSUs for the year ended December 31, 2024 ($222,480 for the year ended December 31, 2023). During the year ended December
31, 2024, 0 shares of common stock underlying RSUs vested (4,270 during the year ended December 31, 2023). During the year ended December
31, 2024, the Company issued 4,270 shares of common stock pursuant to RSUs which were fully vested as of